| Eli Lilly And Company | 75,000 | US$90M | 7.8% |
| Danaher Corporation | 390K | US$74.3M | 6.4% |
| Thermo Fisher Scientific Inc | 116K | US$58.2M | 5.0% |
| Johnson & Johnson | 208K | US$52.8M | 4.6% |
| Unitedhealth Group Incorporated | 108K | US$44.9M | 3.9% |
| Abbvie Inc. | 128K | US$32.2M | 2.8% |
| Ascendis Pharma A/s | 100K | US$26.7M | 2.3% |
| Alnylam Pharmaceuticals, Inc. | 75,400 | US$22.7M | 2.0% |
| Merck & Company, Inc. | 170K | US$21.8M | 1.9% |
| Argenx Se | 22,040 | US$20.4M | 1.8% |
| Gilead Sciences, Inc. | 160K | US$20.2M | 1.7% |
| Boston Scientific Corporation | 460K | US$19.6M | 1.7% |
| Natera, Inc. | 69,500 | US$18.9M | 1.6% |
| Ucb S.a. | 62,800 | US$18.8M | 1.6% |
| Agilent Technologies, Inc. | 133K | US$17.7M | 1.5% |
| Moderna, Inc. | 250K | US$17.5M | 1.5% |
| West Pharmaceutical Services, Inc. | 42,819 | US$15.4M | 1.3% |
| Viatris Inc. | 950K | US$15.1M | 1.3% |
| Oruka Therapeutics, Inc. | 149K | US$14.2M | 1.2% |
| Revolution Medicines, Inc. | 75,000 | US$14M | 1.2% |
| Guardant Health, Inc. | 92,000 | US$13.8M | 1.2% |
| Vaxcyte, Inc. | 233K | US$13.6M | 1.2% |
| Cogent Biosciences, Inc. | 336K | US$13M | 1.1% |
| Cvs Health Corporation | 125K | US$12.9M | 1.1% |
| Veracyte, Inc. | 218K | US$12.8M | 1.1% |
| Enliven Therapeutics, Inc. | 252K | US$12.8M | 1.1% |
| 10x Genomics, Inc. | 324K | US$12.4M | 1.1% |
| Repligen Corporation | 90,000 | US$12.3M | 1.1% |
| Xenon Pharmaceuticals Inc. | 200K | US$12.1M | 1.0% |
| Caris Life Sciences, Inc. | 654K | US$11.7M | 1.0% |
| Privia Health Group, Inc. | 450K | US$11.6M | 1.0% |
| Spyre Therapeutics, Inc. | 128K | US$11.4M | 0.98% |
| Bio-techne Corp | 160K | US$11.3M | 0.98% |
| Royalty Pharma Plc | 200K | US$11.2M | 0.97% |
| Jazz Pharmaceuticals Plc | 46,000 | US$11.1M | 0.96% |
| Kiniksa Pharmaceuticals International, Plc | 170K | US$10.9M | 0.94% |
| Kymera Therapeutics, Inc. | 85,958 | US$9.86M | 0.85% |
| Bruker Corporation | 164K | US$9.84M | 0.85% |
| Insmed Incorporated | 90,000 | US$9.6M | 0.83% |
| Lifestance Health Group, Inc. | 862K | US$9.23M | 0.80% |
| Praxis Precision Medicines, Inc. | 26,000 | US$8.7M | 0.75% |
| Roche Holding Ltd | 20,000 | US$8.24M | 0.71% |
| Axsome Therapeutics, Inc. | 33,000 | US$8.08M | 0.70% |
| Roivant Sciences Ltd. | 228K | US$8.07M | 0.70% |
| Relay Therapeutics, Inc. | 376K | US$7.03M | 0.61% |
| Brightspring Health Services, Inc. | 100K | US$6.97M | 0.60% |
| Elevance Health, Inc. | 18,000 | US$6.96M | 0.60% |
| Alignment Healthcare, Inc. | 285K | US$6.79M | 0.59% |
| Crinetics Pharmaceuticals, Inc. | 176K | US$6.59M | 0.57% |
| Cg Oncology, Inc. | 90,000 | US$6.39M | 0.55% |
| Edwards Lifesciences Corporation | 69,000 | US$6.24M | 0.54% |
| Sartorius Stedim Biotech Sa | 30,000 | US$6.22M | 0.54% |
| Cencora, Inc. | 21,800 | US$6.17M | 0.53% |
| Biogen Inc. | 28,000 | US$6.05M | 0.52% |
| Travere Therapeutics, Inc. | 106K | US$6.02M | 0.52% |
| Mineralys Therapeutics, Inc. | 218K | US$5.88M | 0.51% |
| Disc Medicine, Inc. | 80,000 | US$5.85M | 0.51% |
| Dianthus Therapeutics, Inc. | 59,610 | US$5.81M | 0.50% |
| Mbx Biosciences, Inc. | 105K | US$5.8M | 0.50% |
| Medline Inc. | 145K | US$5.72M | 0.49% |
| Heartflow, Inc. | 185K | US$5.43M | 0.47% |
| Veradermics, Incorporated | 42,000 | US$5.16M | 0.45% |
| Viridian Therapeutics, Inc. | 280K | US$5.14M | 0.44% |
| Mirum Pharmaceuticals, Inc. | 42,800 | US$5.01M | 0.43% |
| Twist Bioscience Corporation | 48,000 | US$4.94M | 0.43% |
| Newamsterdam Pharma Company N.v. | 140K | US$4.74M | 0.41% |
| Zenas Biopharma, Inc. | 185K | US$4.7M | 0.41% |
| Amylyx Pharmaceuticals, Inc. | 260K | US$4.67M | 0.40% |
| Pharvaris N.v. | 128K | US$4.43M | 0.38% |
| Scholar Rock Holding Corporation | 80,000 | US$4.4M | 0.38% |
| Beone Medicines Ltd. Class A | 15,000 | US$4.27M | 0.37% |
| Kestra Medical Technologies, Ltd. | 164K | US$4.18M | 0.36% |
| Intuitive Surgical, Inc. | 10,500 | US$4.18M | 0.36% |
| Alumis Inc. | 146K | US$4.11M | 0.36% |
| Viking Therapeutics, Inc. | 100K | US$3.9M | 0.34% |
| Stoke Therapeutics, Inc. | 118K | US$3.86M | 0.33% |
| Illumina, Inc. | 21,800 | US$3.83M | 0.33% |
| Irhythm Holdings, Inc. | 32,000 | US$3.81M | 0.33% |
| Olema Pharmaceuticals, Inc. | 285K | US$3.57M | 0.31% |
| Jade Biosciences, Inc. | 154K | US$3.41M | 0.30% |
| Trevi Therapeutics, Inc. | 180K | US$3.36M | 0.29% |
| Cytomx Therapeutics, Inc. | 860K | US$3.23M | 0.28% |
| Damora Therapeutics, Inc. | 118K | US$3.07M | 0.27% |
| Gmr Solutions Inc. | 160K | US$2.47M | 0.21% |
| Edgewise Therapeutics, Inc. | 54,000 | US$2.19M | 0.19% |
| Summit Therapeutics Inc. | 145K | US$2.11M | 0.18% |
| Waystar Holding Corp. | 90,000 | US$1.85M | 0.16% |
| First Tracks Biotherapeutics, Inc. | 80,000 | US$1.61M | 0.14% |
| Tyra Biosciences, Inc. | 50,000 | US$1.6M | 0.14% |
| Alamar Biosciences, Inc. | 56,000 | US$1.52M | 0.13% |
| Contineum Therapeutics, Inc. | 80,000 | US$1.31M | 0.11% |
| Insulet Corporation | 8,000 | US$1.22M | 0.11% |
| Outset Medical, Inc. | 280K | US$1.21M | 0.10% |
| Annexon, Inc. | 200K | US$1.14M | 0.10% |
| Upstream Bio, Inc. | 145K | US$1M | 0.09% |
| Ocular Therapeutix, Inc. | 83,621 | US$821K | 0.07% |
| Hemab Therapeutics Holdings, Inc. | 11,500 | US$422K | 0.04% |
| Shoulder Innovations, Inc. | 16,100 | US$327K | 0.03% |
| Immunome, Inc. | 13,670 | US$290K | 0.03% |
| Cyclerion Therapeutics, Inc. | 1,700 | US$5,763 | <0.01% |